AMGN vs FIVE · P/E 24, rev $36.75B vs P/E 28, rev $1.39B
Amgen Inc (AMGN) versus Five Below Inc (FIVE) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Five Below Inc (FIVE) is a specialty retail company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
Not investment advice. Open the AMGN and FIVE stock pages for the full models.
Not investment advice.